MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
5.47
+0.17 (3.21%)
Apr 24, 2026, 3:01 PM CET

MaaT Pharma Revenue

In the year 2025, MaaT Pharma had annual revenue of 4.52M EUR with 40.67% growth. MaaT Pharma had revenue of 2.10M in the half year ending December 31, 2025, with 146.71% growth.

Revenue
4.52M
Revenue Growth
+40.67%
P/S Ratio
22.08
Revenue / Employee
80.79K
Employees
65
Market Cap
99.87M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.52M1.31M40.67%
Dec 31, 20243.22M988.00K44.34%
Dec 31, 20232.23M798.00K55.80%
Dec 31, 20221.43M458.00K47.12%
Dec 31, 2021972.00K--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cellectis67.79M
Fermentalg13.38M
Innate Pharma9.01M
Transgene7.21M
Sensorion5.81M
ABIONYX Pharma4.10M
Adocia3.85M
Nicox3.32M
Revenue Rankings